Narayana Hrudayalaya Q2 Review - Rebound In Elective Surgeries Picking Up: ICICI Direct
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Direct Report
Narayana Hrudayalaya Ltd. posted strong numbers, better than our estimates across all fronts due to the business momentum revival across the hospitals.
Revenues grew 9.4% QoQ to Rs 940.3 crore. On the Ebitda front, margins improved by 241 basis points QoQ to 18% amid lower employee expenditure.
Subsequently, Ebitda grew 26.3% QoQ to Rs 168.9 crore. Adjusted net profit for the quarter was at Rs 99.3 crore with 30.4% QoQ growth.
With the effects of the second wave of the pandemic subsiding, Narayana Hrudayalaya’s Indian operations staged a decent recovery during the quarter.
However, the profitability of flagship Health City, Bengaluru centres remain affected, as compared to the pre-Covid-19 times, given the erosion in international patient mix as well as high-end cardiac sciences based elective work.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.